Related Experiment Video

Updated: Jun 11, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

JAK2V617F/STAT5 signaling pathway promotes cell proliferation through activation of Pituitary Tumor Transforming Gene

Xu-Liang Shen1, Wu Wei, Hong-Liang Xu

  • 1Department of Hematology, Heping Hospital of Changzhi Medical College, Changzhi 046000, China.

Biochemical and Biophysical Research Communications
|July 13, 2010
PubMed

Insights

Gain-of-function mutations in Janus kinase 2 (JAK2) drive myeloproliferative neoplasms. Inhibiting JAK2V617F with AG490 reduces HEL cell proliferation and PTTG1 expression, revealing a key pathway in cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Hematology

Background:

  • Gain-of-function mutations in Janus kinase 2 (JAK2) are implicated in myeloproliferative neoplasms (MPNs).
  • The downstream signaling events of activated JAK2 in MPNs remain incompletely understood.
  • PTTG1 is a potential target gene in aberrant JAK2 signaling pathways.

Purpose of the Study:

  • To investigate the role of the JAK2V617F/STAT5 signaling pathway in the proliferation of HEL cells.
  • To determine the effect of the JAK2V617F kinase inhibitor AG490 on PTTG1 expression.
  • To elucidate the regulatory mechanism of PTTG1 expression by the JAK2V617F/STAT5 pathway.

Main Methods:

  • Treatment of HEL cells with AG490, a JAK2V617F kinase inhibitor.
  • Assessment of cell proliferation using cell counting or viability assays.
  • Quantitative analysis of PTTG1 gene and protein expression.
  • Promoter activity assays to evaluate transcriptional regulation.

Main Results:

  • AG490 effectively inhibited the proliferation of HEL cells.
  • AG490 treatment led to a dose- and time-dependent decrease in PTTG1 expression.
  • Promoter activity analyses indicated that PTTG1 expression is regulated at the transcriptional level.
  • The JAK2V617F/STAT5 signaling pathway was shown to promote cell proliferation via transcriptional activation of PTTG1.

Conclusions:

  • The JAK2V617F/STAT5 signaling pathway plays a significant role in promoting cell proliferation in HEL cells.
  • Transcriptional activation of PTTG1 by the JAK2V617F/STAT5 pathway contributes to cell proliferation.
  • AG490 demonstrates potential as a therapeutic agent by inhibiting JAK2V617F and its downstream effects.

More Related Videos

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...